QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
about
In silico and in vivo anti-malarial studies of 18β glycyrrhetinic acid from Glycyrrhiza glabraChemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review.Drug target identification in protozoan parasites.QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum.
P2860
QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@en
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@nl
type
label
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@en
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@nl
prefLabel
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@en
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@nl
P2093
P921
P1476
QSAR, docking and ADMET studie ...... ing enzyme from P. falciparum.
@en
P2093
R S Bhakuni
Sangeeta Dhawan
Tabish Qidwai
P304
P356
10.2174/138161212803582397
P577
2012-01-01T00:00:00Z